chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vomiting; Sore arm; Bad headache; Fatigued/Tired; A spontaneous report was received from a consumer (patient) concerning a 73 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like a sore arm, a bad headache, fatigued/tired, and vomiting.  The patient's medical history was not provided. Relevant concomitant medications were reported. The patient is taking blood pressure medicines.  On 13-JAN-2021, the patient received their first of two planned doses of mRNA-1273(Batch number 012L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 09-FEB-2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273( Batch Number 010M20A ) intramuscularly for prophylaxis of COVID-19 infection.  On  09-FEB-2021, the patient experienced a sore arm, a bad headache and was fatigued/tired.   On 18-FEB-2021, the patient experienced the event vomiting.  Treatment details were not reported.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcomes of the events, a sore arm, a bad headache and was fatigued/tired were considered resolved on 12 Feb 2021. The outcome of the event, vomiting was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Certain items such as my face wash, toner and nail polish all smell really bad now.  They don't smell like they normally do at all.  Items I eat or drink taste like what I am smelling and the smell appears randomly.  I can't pinpoint what the smell is or what the taste is like but I've never smelled or tasted anything quite like it.  It's not a pleasant smell or taste at all.  The best I can describe the smell is that maybe of chemistry lab from high school or the smell of mixing certain items for experimentation during chemistry class or that of chemicals used to develop film used in photography class.  Things I have eaten and drank since my vaccine no longer taste the same.  These symptoms started to become noticeable at around 6:30 PM on 5/4/2020 (the day of my shot).  I took a sip of my soda and immediately dumped it out.  I did wake up the next day (5/5/2020) with a massive headache, fever, chills, nausea and exhaustion.  Those symptoms went away on 5/6/2020 but the smell and taste issues are still present.         I did have COVID back in December 2020 and did lose my smell and taste about two weeks after.  I never fully regained my smell but I did regain my taste.  I've also been experiencing some GI issues.  I received my first vaccine on 3/31/2020 and only had minor issues - slight headache and some chills and exhaustion.
Red, swollen about 4-5 inches below injection site. Fever 100 degrees C for 1 day. Problems mainly arm; unable to lift. MD prescribed BACTRIM and BENADRYL. Required IV antibiotics, 4 days hospitalization. Area swollen from shoulder to elbow; now recovered.   10/22/09:  Hospital Medical Records and Discharge Summary received for dates of service 9/17/09 to 9/20/09.  Dx:  Severe allergic reaction pneumococcal vaccination, Cellulitis of the right arm complicating vaccination injection, hypertension, Assessment:  Presented with swelling, warmth, erythema and spreading lymphangitis up the arm.  She also developed swelling and erythema in the face. BP 189/92.  Rehydrated and treated with antibiotic therapy, prednisone as well as antihistamine medication.  Discharged dramatically improved.  To follow up with allergy specialist.    ICD Codes:  72981, 99939, 6823, V854, E9488, E8490, 27800, 4019, 3384, 56409.
In observation area after 2nd dose of COVID vaccine, patient reported dizziness and bilateral leg numbness. O2 given, pt denies SOB or rash/itching. After a few minutes, pt reports symptoms resolved, and was able to ambulate out of clinic in stable condition.
12/01/21 patient presents to EC ED for "chest tightness and dyspnea". PMHx of "PMH CAD, HFrEF, HTN, HLD, obesity"
Pain in Lower back right side and lower abdomen. Went to er Thursday morning because pain was so bad and that afternoon they performed Appendectomy April 15, 2021
Apparent arthus reaction of RA swelling and redness from right elbow to shoulder area 48 hours post vaccination. Given Benadryl injection at MD office and continued Benadryl orally 3 days then resolved.
Severe tinnitus post vaccine. Has not abated for a full month after vaccine . No tinnitus history prior to vaccination.
I have Had A MIGRAINE Along with HIGH BLOOD PRESSURE... It started 2 weeks after my 2nd Pfizer Shot...  I was admitted into the hospital because after A Cat Scan, MRI, And A Spinal Tap looking for Menengitis They Couldn't Find ANYTHING WRONG... I was in the Hospital for 8 days... They where unsure WHAT WAS WRONG SO THEY TREATED ME WITH MANY DIFFERENT MEDICATIONS INCLUDING HEPRINE FOR BLOOD CLOTS... AS OF TODAY 4/23/2021.. I CONTINUE TO EXPERIENCE THESE UNBEARABLE HEADACHES... HAVEN'T SLEPT IN A MONTH.. AND I CONTINUE TO HAVE SUPER HIGH BLOOD PRESSURE... IF THIS CONTINUES I AM NOT SURE HOW I WOULD LIVE... THE PAIN IS HORRIBLE... SO SO BAD
feels like a needle is stuck in his muscle.; Arm of injection stinging; Arm of injection hurts; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (feels like a needle is stuck in his muscle.), PAIN (Arm of injection stinging) and VACCINATION SITE PAIN (Arm of injection hurts) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included Oral surgery.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PAIN (Arm of injection stinging) and VACCINATION SITE PAIN (Arm of injection hurts). On an unknown date, the patient experienced PARAESTHESIA (feels like a needle is stuck in his muscle.). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (feels like a needle is stuck in his muscle.), PAIN (Arm of injection stinging) and VACCINATION SITE PAIN (Arm of injection hurts) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications  includes Antibiotic, Pain medications.   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: Follow up received on 22-MAY-2021. Attached ADR form contain non significant information. On 24-May-2021: Follow up received on 24-MAY-2021. Contain significant information additional event added
Infection at injection site; Injection site had a red mark; Injection site was swollen; Injection site was tender; Injection site was itching; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE SWELLING (Injection site was swollen), INJECTION SITE PAIN (Injection site was tender), INJECTION SITE PRURITUS (Injection site was itching) and INJECTION SITE INFECTION (Infection at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Reported as allergic to PCN).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE SWELLING (Injection site was swollen), INJECTION SITE PAIN (Injection site was tender) and INJECTION SITE PRURITUS (Injection site was itching). On 12-Jan-2021, the patient experienced INJECTION SITE INFECTION (Infection at injection site). On 17-Jan-2021, INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE PAIN (Injection site was tender) outcome was unknown. At the time of the report, INJECTION SITE ERYTHEMA (Injection site had a red mark), INJECTION SITE PRURITUS (Injection site was itching) and INJECTION SITE INFECTION (Infection at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
The day after my vaccine I had nausea, aching muscles, ovaries  pain and I was in bed for about three weeks. I had breakthrough bleeding/periodic bleeding, I went to my gynecologist  on February 15th 2022 and they did a ultra sound and they found a large cist on my left ovaries about 3-4 inches. I was prescribed Provera to see if they can shrink the cist and I just had a follow up ultra sound and it has gotten larger instead of shrinking. In about two months if pain continues I will have to under go surgery so this is still a ongoing issue.
Headache started 8 hours after injection. Body aches all over starting at 5am. Fever of 104.1 at 5:30am.
swollen lymph node on left side of neck; Initial information was received on 09-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or nurse.  This case involves a female patient (unknown age) who experienced swollen lymph node on left side of neck (lymphadenopathy), while he/she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On 19-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and expiry date not reported) via unknown route in the right arm for prophylactic vaccination.  On 21-Oct-2020, the patient developed non-serious swollen lymph node on left side of neck (lymphadenopathy) 2 days following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
UNSURE IF RELATED TO VACCINE OR NOT, PATIENT EXPIRED 48HOURS FOLLOWING COVID VACCINE ADMINISTRATION
Extreme fatigue, wooziness, chills, diarrhea and inability to get out of bed for a day
Pt C/o coughing, SOB,and throat irritation 25 minutes after the vaccine was administered.  Also reported that her throat and neck felt swollen and tongue began to feel "thick".
mouth on fire; tongue on fire; heart racing; chest felt funny; metal taste in the mouth; This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (mouth on fire), TONGUE DISCOMFORT (tongue on fire), PALPITATIONS (heart racing), CHEST DISCOMFORT (chest felt funny) and DYSGEUSIA (metal taste in the mouth) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Steroid therapy NOS, Allergy, Hormone therapy, Allergy and Shellfish allergy.    On 01-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL DISCOMFORT (mouth on fire), TONGUE DISCOMFORT (tongue on fire), PALPITATIONS (heart racing), CHEST DISCOMFORT (chest felt funny) and DYSGEUSIA (metal taste in the mouth). At the time of the report, ORAL DISCOMFORT (mouth on fire), TONGUE DISCOMFORT (tongue on fire), PALPITATIONS (heart racing), CHEST DISCOMFORT (chest felt funny) and DYSGEUSIA (metal taste in the mouth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Rash on arms, abdomen and legs. Itching and hand swelling. Took oral BENADRYL and used cortisone cream.
Patient had received 2 doses of vaccine in home country in Spring 2021. On a visit in August 2021, received a Pfizer booster on 8/21. Felt well for about 60 hours, travelled back to home country. The evening (local time) of 8/23, patient developed some dizziness. The next morning 8/24, noted worsening dizziness, headache, dysarthria. Presented to ED and was admitted to the hospital. Diagnosed with Transient Ischemic Attack of posterior circulation. Discharged from hospital after 24h admission to stroke ward.
have swelling and pain in lymph node; 48 hours after receiving shot my son reported pain in arm pit.; have swelling and pain in lymph node; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 15 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16May2021 13:00 (Lot number: EW0172) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 04May2021 14:00, outcome "recovering" and all described as "have swelling and pain in lymph node"; PAIN IN EXTREMITY (non-serious) with onset 04May2021 14:00, outcome "recovering", described as "48 hours after receiving shot my son reported pain in arm pit.". Therapeutic measures were taken as a result of lymphadenopathy, pain in extremity, lymph node pain. No follow-up attempts are possible. No further information is expected.  Additional information: 48 hours after receiving shot my son reported pain in arm pit. Continues to have swelling and pain in lymph node. Because vaccine was recently opened up to kids 12-year-old and up I wanted to report this.  No other vaccine in four weeks and Other medications in two weeks.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing). Allergies were not known. Concomitant medication(s) included: EXEMESTANE, start date: 01Nov2022, stop date: 25Mar2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: after stopping tested positive and had covid 19 symptoms again. Therapeutic measures were taken as a result of drug ineffective, covid-19. Pfizer COVID 19 treatment was received from 06Mar2023 to 11Mar2023. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
When exiting the exam room after receiving immunizations, the patient passed out and landed face first on the tile floor. Patient sustained laceration to forehead and jaw.
Symptoms:  24h after vaccine developed headache, body aches, fever, nausea, vomiting.  48h after vaccine developed chest pain and tightness.
Possibly Mastitis; Breast was hard, red, and sore; Milk production dropped; Clogged duct; Flu like symptoms; Received vaccine while breastfeeding; A spontaneous report was received from a consumer who was also a 33-years-old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced received vaccine while breastfeeding (maternal exposure during breast feeding), clogged duct (galactostasis), possible mastitis (mastitis), flu like symptoms (influenza like illness), milk production dropped (suppressed lactation), and breast was hard, red, and sore (breast tenderness).   The patient's medical history included eczema.  Products known to have been used by the patient, within two weeks prior to the event, included pre-natal vitamins.  The patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) on 31 Dec 2020. On 28 Jan 2021, approximately one day prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (batch number 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   The patient received the vaccine while breastfeeding and reported having a clogged duct and possible mastitis.  She began to experience flu like symptoms on 29 Jan 2021.  She had a fever and missed pumping breast milk.  On 30 Jan 2021 her milk production was about half of the typical amount.  The flu like symptoms resolved on 31 Jan 2021.  On 01 Feb 2021 her breast became hard, red, and sore.  On 02 Feb 2021 her breast symptoms resolved; however, her milk production was 65-70% of normal. She treated the events with acetaminophen and magnesium sulfate dissolved in water.    The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events was not applicable.   The outcome of the events clogged duct, possible mastitis, milk production dropped, and were not reported.  The outcome of the event, received vaccine while breastfeeding, was considered resolved on 28 Jan 2021. The outcome of the event, flu like symptoms, was considered resolved on 31 Jan 2021. The outcome of the event, breast was hard, red, and sore, was considered resolved on 02 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Urticaria at site -> spreading upward to include trunk, old c/o tongue - Responded to BENADRYL
No documentation from the event is in patient's medical records.  Patient describes adverse reaction as baseball size nodule with redness around site and dark streaks from shot area around arm into chest and back at underarm level.  Patient saw physician on 7 Mar 2004 and was not advised to be seen for further treatment.  This event was not documented.  The doctor at the time called VAERS and spoke with them about the event, no report can be found to date.
Fever overnoc of 105.8 measured at home by parents. Emesis. Required trip to ER.
administered with only adjuvant; administered with only adjuvant; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 57-year-old male patient who received Herpes zoster (Shingrix) (batch number 7C483, expiry date 14th November 2022) for prophylaxis.   On 17th September 2021, the patient received Shingrix. On 17th September 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient was administered with only the AS01B adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This is one of four cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021206993:same reporter US-GLAXOSMITHKLINE-US2021206991:same reporter US-GLAXOSMITHKLINE-US2021206994:same reporter
Patient stated that approx. a day after she received her booster dose, she noticed that there was redness, tenderness, and slight inflammation around the injection site reaction. Patient stated that she took ibuprofen. Pt could not specify if getting worse or remained the same since the reaction first appeared. Recommended to keep a look out for worsening symptoms.
presented @ ER w/t104 & sz nurse in ER states, probable febrile seizure only, no other findings; MD felt this was due to parents giving pt PCn instead of APAP;
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial did not undergone any temperature excursions.  No treatment information was provided
numbness down left arm into pinky and ring finger; numbness up left arm into neck and face; nausea
Client received only the DTaP and IPV component of the Pentacel. Wasn't reconstituted with the HIB component.
One week to the day after the injection, on February 21, 2021, I developed large red itchy blotch on left arm at injection site.  About 3-4 inches in size.  Two days later, today, it is still there.  I have since learned that this has a name:  "Covid arm".  And that it is known only to occur with the Moderna vaccine, and more common in women than men.  It is quite itchy, warm to the touch.  I have been applying ice and using OTC anti-itch cream.
Patient was vaccinated with Pfizer #1 on 3/22/2021 per his vaccine card. The computer record showed he received Moderna that day, so he was moved into the Moderna vaccine lane. He received a second dose of Moderna 4/19/2021.  When the scribe applied the sticker to the vaccine card, it showed that the actual dose was Pfizer. Troubleshooting: This was missed in screening two times; the scribe and vaccinator did not ask birth date and did not ask to see the vaccine card prior to injection., and the site is doing two different vaccines today. MD counseled the patient.
This spontaneous report as received from a nurse practitioner refers to a 71 year old male patient with high blood pressure, diabetes and gout. On an unknown date, in December 2010, the patient was vaccinated with ZOSTAVAX (dose, route, lot number and expiration date not reported). Concomitant therapies included allopurinol (manufacturer unknown), lisinopril (+) hydrochlorothiazide (manufacturer unknown) and metformin (manufacturer unknown). On 12-SEP-2014 the patient developed shingles. The patient sought medical attention. On 15-SEP-2014, the patient started VALTREX. At the time of the report the outcome of shingles was reported as recovering. Additional information has been requested.